Geburtshilfe Frauenheilkd 2016; 76(06): 709-717
DOI: 10.1055/s-0041-111697
Original Article
GebFra Science
Georg Thieme Verlag KG Stuttgart · New York

Osteopontin and Integrin αvβ3 Expression during the Implantation Window in IVF Patients with Elevated Serum Progesterone and Oestradiol Level

Expression von Osteopontin und Integrin αvβ3 während des Implantationsfensters in IVF-Patientinnen mit erhöhten Progesteron- und Östradiolwerten
Z. He   *
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
Y. Ma   *
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
L. Li
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
J. Liu
3   Institute of Molecular and Clinical Medicine, Kunming Medical University, Chengong New District, Kunming, Peopleʼs Republic of China
,
H. Yang
2   Department of Pathology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
C. Chen
4   Department of Obstetrics and Gynecology, Reproductive Medical Centre, Peking University Third Hospital, Haidian District, Beijing, Peopleʼs Republic of China
,
N. Lin
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
Y. Bai
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
R. Ma
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
R. Li
4   Department of Obstetrics and Gynecology, Reproductive Medical Centre, Peking University Third Hospital, Haidian District, Beijing, Peopleʼs Republic of China
,
Z. Wu
1   Department of Reproduction and Genetics, Reproductive Medical Centre, The Affiliated Hospital of Kunming University of Science and Technology, The First Peopleʼs Hospital of Yunnan Province, Kunming, Peopleʼs Republic of China
,
J. Qiao
4   Department of Obstetrics and Gynecology, Reproductive Medical Centre, Peking University Third Hospital, Haidian District, Beijing, Peopleʼs Republic of China
› Author Affiliations
Further Information

Publication History

received 23 September 2015
revised 20 December 2015

accepted 20 December 2015

Publication Date:
27 June 2016 (online)

    Permissions and Reprints

Corrected by:

Correction: Osteopontin and Integrin αvβ3 Expression during the Implantation Window in IVF Patients with Elevated Serum Progesterone and Oestradiol LevelGeburtshilfe Frauenheilkd 2016; 76(06): e1-e1
DOI: 10.1055/s-0036-1585140

Abstract

Background: To explore whether endometrial receptivity is determined by osteopontin (OPN) and integrin αvβ3 expression in women with elevated serum progesterone (P) and/or oestradiol (E2) who are undergoing in vitro fertilisation (IVF). Methods: According to serum hormone levels on the day of HCG administration, 33 infertile women were divided into 3 groups: the high E2, high P, and high E2 and P groups. The control group included 11 fertile, healthy women. Endometrial biopsy was performed on ovulation day + 7 to + 8 for all study participants, and the mRNA and protein expression levels of OPN and integrin αvβ3 were analyzed. Result: No statistically significant differences regarding OPN and integrin αvβ3 expression were found between infertile patients in the high P, high E2, high E2 and P and control groups. There was no significant correlation between OPN and integrin αvβ3 staining intensity during the implantation window biopsy in any of the groups studied. Conclusion: Endometrial OPN and integrant αvβ3 expression/co-expression is not impaired during the window of implantation in patients with high P, high E2, or high E2 and P levels. The clinical value of assessing endometrial receptivity with OPN and integrin αvβ3 seems to be uncertain.

Zusammenfassung

Hintergrund: Ziel der Studie war es zu untersuchen, ob die Rezeptivität des Endometriums von der Osteopontin- (OPN-) und Integrin αvβ3-Expression bestimmt wird bei Frauen mit erhöhten Progesteron-(P-) und/oder Östradiol-(E2-)Konzentrationen, die sich einer In-vitro-Fertilisation (IVF) unterziehen. Methoden: Basierend auf der Messung des Hormonspiegels am Tage der hCG-Gabe wurden 33 unfruchtbare Frauen in 3 Gruppen wie folgt eingeteilt: hoher E2-, hoher P- und hoher E2- und P-Spiegel. Die Kontrollgruppe bestand aus 11 gesunden fruchtbaren Frauen. Eine Biopsie des Endometriums wurde am 7. oder 8. Tag nach der Ovulation bei allen Studienteilnehmende durchgeführt, und die mRNA und Protein-Expressionsspiegeln von OPN und Integrin αvβ3 wurden ausgewertet. Ergebnisse: Bezüglich der Exprimierung von OPN und Integrin αvβ3 fanden sich keine statistisch signifikanten Unterschiede zwischen den unfruchtbaren Patientinnen in den Gruppen mit hohen P- oder E2-Spiegeln, der Gruppe mit hohen E2- und P-Spiegeln und der Kontrollgruppe. In den entnommenen Biopsaten konnte bei keiner der untersuchten Gruppen eine signifikante Korrelation zwischen der Färbungsintensität für OPN und Integrin αvβ3 und dem Implantationsfenster festgestellt werden. Schlussfolgerungen: Die Expression und Koexpression von OPN und Integrin αvβ3 im Endometrium sind während des Implantationsfensters nicht beeinträchtigt bei Patientinnen mit hohen P- oder E2-Spiegeln bzw. hohen E2- und P-Spiegeln. Der klinische Nutzen einer auf die Messung der Expression von OPN- und Integrin αvβ3 basierenden Bewertung der Rezeptivität des Endometriums scheint fraglich zu sein.

Key words

endometrial receptivity - IVF - elevated hormone levels - osteopontin - integrin αvβ3

Schlüsselwörter

Rezeptivität des Endometriums - IVF - erhöhte Hormonspiegel - Osteopontin - Integrin αvβ3

* Co-author: Zhenlin He and Yanping Ma are joint first authors of this article.


 

  • References

  • 1 Achache H, Revel A. Endometrial receptivity markers, the journey to successful embryo implantation. Hum Reprod Update 2006; 12: 731-746
    CrossrefGoogle Scholar
  • 2 Ubaldi F, Camus M, Smitz J et al. Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil Steril 1996; 66: 275-280
    Google Scholar
  • 3 Bosch E, Valencia I, Escudero E et al. Premature luteinization during gonadotropin-releasing hormone antagonist cycles and its relationship with in vitro fertilization outcome. Fertil Steril 2003; 80: 1444-1449
    CrossrefGoogle Scholar
  • 4 Arslan M, Bocca S, Arslan E et al. Cumulative exposure to high estradiol levels during the follicular phase of IVF cycles negatively affects implantation. J Assist Reprod Genet 2007; 24: 111-117
    CrossrefGoogle Scholar
  • 5 Wu Z, Li R, Ma YP et al. Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles. Reprod Biomed Online 2012; 24: 511-520
    CrossrefGoogle Scholar
  • 6 Castelbaum AJ, Wheeler J, Coutifaris C et al. Timing of the endometrial biopsy may be critical for the accurate diagnosis of luteal phase deficiency. Fertil Steril 1994; 61: 443-447
    Google Scholar
  • 7 Borthwick JM, Charnock-Jones DS, Tom BD et al. Determination of the transcript profile of human endometrium. Mol Hum Reprod 2003; 9: 19-33
    CrossrefGoogle Scholar
  • 8 Apparao KB, Murray MJ, Fritz MA et al. Osteopontin and its receptor alphavbeta(3) integrin are coexpressed in the human endometrium during the menstrual cycle but regulated differentially. J Clin Endocrinol Metab 2001; 86: 4991-5000
    CrossrefGoogle Scholar
  • 9 von Wolff M, Strowitzki T, Becker V et al. Endometrial osteopontin, a ligand of beta3-integrin, is maximally expressed around the time of the “implantation window”. Fertil Steril 2001; 76: 775-781
    CrossrefGoogle Scholar
  • 10 Lessey BA. Implantation defects in infertile women with endometriosis. Ann N Y Acad Sci 2002; 955: 265-280
    CrossrefGoogle Scholar
  • 11 Makker A, Singh MM. Endometrial receptivity: clinical assessment in relation to fertility, infertility, and antifertility. Med Res Rev 2006; 26: 699-746
    CrossrefGoogle Scholar
  • 12 Strowitzki T, Germeyer A, Popovici R et al. The human endometrium as a fertility-determining factor. Hum Reprod Update 2006; 12: 617-630
    CrossrefGoogle Scholar
  • 13 Boroujerdnia MG, Nikbakht R. Beta3 integrin expression within uterine endometrium and its relationship with unexplained infertility. Pak J Biol Sci 2008; 11: 2495-2499
    CrossrefGoogle Scholar
  • 14 Ceydeli N, Kaleli S, Calay Z et al. Difference in alpha(v)beta3 integrin expression in endometrial stromal cell in subgroups of women with unexplained infertility. Eur J Obstet Gynecol Reprod Biol 2006; 126: 206-211
    CrossrefGoogle Scholar
  • 15 Lessey BA, Castelbaum AJ, Sawin SW et al. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994; 79: 643-649
    CrossrefGoogle Scholar
  • 16 Savaris RF, Pedrini JL, Flores R et al. Expression of alpha 1 and beta 3 integrins subunits in the endometrium of patients with tubal phimosis or hydrosalpinx. Fertil Steril 2006; 85: 188-192
    CrossrefGoogle Scholar
  • 17 Casals G, Ordi J, Creus M et al. Osteopontin and alphavbeta3 integrin as markers of endometrial receptivity: the effect of different hormone therapies. Reprod Biomed Online 2010; 21: 349-359
    CrossrefGoogle Scholar
  • 18 DuQuesnay R, Wright C, Aziz AA et al. Infertile women with isolated polycystic ovaries are deficient in endometrial expression of osteopontin but not alphavbeta3 integrin during the implantation window. Fertil Steril 2009; 91: 489-499
    CrossrefGoogle Scholar
  • 19 Peters AJ, Lloyd RP, Coulam CB. Prevalence of out-of-phase endometrial biopsy specimens. Am J Obstet Gynecol 1992; 166: 1738-1745
    CrossrefGoogle Scholar
  • 20 Shoupe D, Mishell DRJ, Lacarra M et al. Correlation of endometrial maturation with four methods of estimating day of ovulation. Obstet Gynecol 1989; 73: 88-92
    Google Scholar
  • 21 Casals G, Ordi J, Creus M et al. Osteopontin and alphavbeta3 integrin expression in the endometrium of infertile and fertile women. Reprod Biomed Online 2008; 16: 808-816
    CrossrefGoogle Scholar
  • 22 Noyes RW, Hertig AT, Rock J. Dating the endometrial biopsy. Am J Obstet Gynecol 1975; 122: 262-263
    CrossrefGoogle Scholar
  • 23 Creus M, Ordi J, Fábregues F et al. alphavbeta3 integrin expression and pinopod formation in normal and out-of-phase endometria of fertile and infertile women. Hum Reprod 2002; 17: 2279-2286
    CrossrefGoogle Scholar
  • 24 Ordi J, Creus M, Ferrer B et al. Midluteal endometrial biopsy and alphavbeta3 integrin expression in the evaluation of the endometrium in infertility: implications for fecundity. Int J Gynecol Pathol 2002; 21: 231-238
    CrossrefGoogle Scholar
  • 25 Budwit-Novotny DA, McCarty KS, Cox EB et al. Immunohistochemical analyses of estrogen receptor in endometrial adenocarcinoma using a monoclonal antibody. Cancer Res 1986; 46: 5419-5425
    Google Scholar
  • 26 Lessey BA, Albelda S, Buck CA et al. Distribution of integrin cell adhesion molecules in endometrial cancer. Am J Pathol 1995; 146: 717-726
    Google Scholar
  • 27 Ruan HC, Zhu XM, Luo Q et al. Ovarian stimulation with GnRH agonist, but not GnRH antagonist, partially restores the expression of endometrial integrin beta3 and leukaemia-inhibitory factor and improves uterine receptivity in mice. Hum Reprod 2006; 21: 2521-2529
    CrossrefGoogle Scholar
  • 28 Creus M, Balasch J, Ordi J et al. Integrin expression in normal and out-of-phase endometria. Hum Reprod 1998; 13: 3460-3468
    CrossrefGoogle Scholar
  • 29 Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001; 25: 402-408
    CrossrefPubMedGoogle Scholar
  • 30 Salamonsen LA. Role of proteases in implantation. Rev Reprod 1999; 4: 11-22
    CrossrefGoogle Scholar
  • 31 Nikas G, Develioglu OH, Toner JP et al. Endometrial pinopodes indicate a shift in the window of receptivity in IVF cycles. Hum Reprod 1999; 14: 787-792
    CrossrefGoogle Scholar
  • 32 Giudice LC. Potential biochemical markers of uterine receptivity. Hum Reprod 1999; 14 (Suppl. 02) 3-16
    CrossrefGoogle Scholar
  • 33 Lessey BA. Adhesion molecules and implantation. J Reprod Immunol 2002; 55: 101-112
    CrossrefGoogle Scholar
  • 34 Lessey BA. Two pathways of progesterone action in the human endometrium: implications for implantation and contraception. Steroids 2003; 68: 809-815
    CrossrefGoogle Scholar
  • 35 Franchi A, Zaret J, Zhang X et al. Expression of immunomodulatory genes, their protein products and specific ligands/receptors during the window of implantation in the human endometrium. Mol Hum Reprod 2008; 14: 413-421
    CrossrefGoogle Scholar
  • 36 Quenby S, Anim-Somuah M, Kalumbi C et al. Different types of recurrent miscarriage are associated with varying patterns of adhesion molecule expression in endometrium. Reprod Biomed Online 2007; 14: 224-234
    CrossrefGoogle Scholar
  • 37 Somkuti SG, Yuan L, Fritz M et al. Epidermal growth factor and sex steroids dynamically regulate a marker of endometrial receptivity in Ishikawa cells. J Clin Endocrinol Metab 1997; 82: 2192-2197
    CrossrefGoogle Scholar
  • 38 Thomas K, Thomson AJ, Wood SJ et al. Endometrial integrin expression in women undergoing IVF and ICSI: a comparison of the two groups and fertile controls. Hum Reprod 2003; 18: 364-369
    CrossrefGoogle Scholar
  • 39 Thomas K, Thomson A, Wood S et al. Endometrial integrin expression in women undergoing in vitro fertilization and the association with subsequent treatment outcome. Fertil Steril 2003; 80: 502-507
    CrossrefGoogle Scholar
  • 40 Kao LC, Tulac S, Lobo S et al. Global gene profiling in human endometrium during the window of implantation. Endocrinology 2002; 143: 2119-2138
    CrossrefGoogle Scholar
  • 41 Li R, Qiao J, Wang L et al. MicroRNA array and microarray evaluation of endometrial receptivity in patients with high serum progesterone levels on the day of hCG administration. Reprod Biol Endocrinol 2011; 9: 29
    CrossrefGoogle Scholar
  • 42 Riesewijk A, Martín J, van Os R et al. Gene expression profiling of human endometrial receptivity on days LH+2 versus LH+7 by microarray technology. Mol Hum Reprod 2003; 9: 253-264
    CrossrefGoogle Scholar
  • 43 Cho S, Ahn YS, Choi YS et al. Endometrial osteopontin mRNA expression and plasma osteopontin levels are increased in patients with endometriosis. Am J Reprod Immunol 2009; 61: 286-293
    CrossrefGoogle Scholar
  • 44 Casals G, Ordi J, Creus M et al. Expression pattern of osteopontin and alphavbeta3 integrin during the implantation window in infertile patients with early stages of endometriosis. Hum Reprod 2012; 27: 805-813
    CrossrefGoogle Scholar
  • 45 Hofmann GE, Bergh PA, Guzman I et al. Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum Reprod 1993; 8: 695-698
    CrossrefGoogle Scholar
  • 46 Papanikolaou EG, Kolibianakis EM, Pozzobon C et al. Progesterone rise on the day of human chorionic gonadotropin administration impairs pregnancy outcome in day 3 single-embryo transfer, while has no effect on day 5 single blastocyst transfer. Fertil Steril 2009; 91: 949-952
    CrossrefPubMedGoogle Scholar